Formosa News
Date: 2019/01/15
breakthrough finding at Academia Sinica could help doctors double the life expectancy of their brain cancer patients. Researchers at Academia Sinica have found a way to very effectively deliver medicine to the brain – by injecting a growth factor to temporarily disarm the brain’s natural shield against chemotherapy. This technique is about to start clinical trials in the U.S. Researchers say it could be used to treat a range of brain diseases.
Data from the past 30 years show that patients diagnosed with brain cancer had an average life expectancy of just 12 to 15 months. The poor prognosis is due to the brain’s own protective mechanisms, which prevent chemotherapy from killing cancer cells. But there’s new hope for cancer sufferers. Academia Sinica has developed a new technique that could increase their life expectancy by up to two times. [FULL STORY]